Immunohistochemistry

Association of metabolomics with PD-1 inhibitor plus chemotherapy outcomes in patients with advanced non-small-cell lung cancer
Liang Zheng, Fang Hu, Lin Huang, Jun Lu, Xiaohua Yang, Jianlin Xu, Shuyuan Wang, Yinchen Shen, Runbo Zhong, Tianqing Chu, Wei Zhang, Ying Li, Xiaoxuan Zheng, Baohui Han, Hua Zhong, Wei Nie, Xueyan Zhang

Journal for ImmunoTherapy of Cancer Apr 2024, 12 (4) e008190; DOI: 10.1136/jitc-2023-008190
Intratumoral administration of the immunologic adjuvant AS01_B in combination with autologous CD1c (BDCA-1)⁺/CD141 (BDCA-3)⁺ myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma
Jens Tijtgat, Xenia Geeraerts, Anais Boisson, Latoya Stevens, Manon Vounckx, Iris Dirven, Julia Katharina Schwarze, Steven Raeymaeckers, Ramses Forsyth, Ivan Van Riet, Sandra Tuyaerts, Karen Willard-Gallo, Bart Neyns

Journal for ImmunoTherapy of Cancer Jan 2024, 12 (1) e008148; DOI: 10.1136/jitc-2023-008148
Cancer-oocyte SAS1B protein is expressed at the cell surface of multiple solid tumors and targeted with antibody-drug conjugates
Arabinda Mandal, Jagathpala Shetty, Christine A Tran, Walter C Olson, Mriganka Mandal, Bhupal Ban, Eusebio S Pires, Sara J Adair, Todd W Bauer, Craig L Slingluff, John C Herr

Journal for ImmunoTherapy of Cancer Mar 2024, 12 (3) e008430; DOI: 10.1136/jitc-2023-008430
Unveiling the tumor immune microenvironment of organ-specific melanoma metastatic sites
Jordan W Conway, Robert V Rawson, Serigne Lo, Tasnia Ahmed, Ismael A Vergara, Tuba N Gide, Grace Heloise Attrill, Matteo S Carlino, Robyn P M Saw, John F Thompson, Andrew J Spillane, Kerwin F Shannon, Brindha Shivalingam, Alexander Maxwell Menzies, James S Wilmott, Georgina V Long, Richard A Scolyer, Ines Pires da Silva

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e004884; DOI: 10.1136/jitc-2022-004884
Vinblastine resets tumor-associated macrophages toward M1 phenotype and promotes antitumor immune response
Yi-Na Wang, Yuan-Yuan Wang, Jin Wang, Wen-Juan Bai, Nai-Jun Miao, Jing Wang

Journal for ImmunoTherapy of Cancer Aug 2023, 11 (8) e007253; DOI: 10.1136/jitc-2023-007253
Paired primary and metastatic lesions of patients with ipilimumab-treated melanoma: high variation in lymphocyte infiltration and HLA-ABC expression whereas tumor mutational load is similar and correlates with clinical outcome
Mark A J Gorris, Lieke L van der Woude, Leonie I Kroeze, Kalijn Bol, Kiek Verrijp, Avital L Amir, Jelena Meek, Johannes Textor, Carl G Figdor, I Jolanda M de Vries

Journal for ImmunoTherapy of Cancer May 2022, 10 (5) e004329; DOI: 10.1136/jitc-2021-004329
Combination of AKT1 and CDH1 mutations predicts primary resistance to immunotherapy in dMMR/MSI-H gastrointestinal cancer
Zhenghang Wang, Qi Zhang, Changsong Qi, Yuezong Bai, Feilong Zhao, Hui Chen, Zhongwu Li, Xicheng Wang, Mifen Chen, Jifang Gong, Zhi Peng, Xiaotian Zhang, Jinping Cai, Shiqing Chen, Xiaochen Zhao, Lin Shen, Jian Li

Journal for ImmunoTherapy of Cancer Jun 2022, 10 (6) e004703; DOI: 10.1136/jitc-2022-004703
Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockade
Julie Stein Deutsch, Jonathan Lai, Kara M Schenk, Abha Soni, Elizabeth M Will, Logan L Engle, Haiying Xu, Alexandra Ogurtsova, Vrinda Madan, Jennifer K Chong, Daphne Wang, Benjamin F Green, Peter Nguyen, Megan D Schollenberger, Evan J Lipson, Janis M Taube

Journal for ImmunoTherapy of Cancer Dec 2023, 11 (12) e007463; DOI: 10.1136/jitc-2023-007463
Comparison of SP263 and 22C3 immunohistochemistry PD-L1 assays for clinical efficacy of adjuvant atezolizumab in non-small cell lung cancer: results from the randomized phase III IMpower010 trial
Caicun Zhou, Minu K Srivastava, Hao Xu, Enriqueta Felip, Heather Wakelee, Nasser Altorki, Martin Reck, Rüdiger Liersch, Anna Kryzhanivska, Satoshi Oizumi, Hiroshi Tanaka, John Hamm, Steven L McCune, Elizabeth Bennett, Barbara Gitlitz, Virginia McNally, Marcus Ballinger, Mark McCleland, Wei Zou, Meghna Das Thakur, Silvia Novello

Journal for ImmunoTherapy of Cancer Oct 2023, 11 (10) e007047; DOI: 10.1136/jitc-2023-007047
Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors
Yuxiang Ma, Jinhui Xue, Yuanyuan Zhao, Yang Zhang, Yan Huang, Yunpeng Yang, Wenfeng Fang, Ye Guo, Qun Li, Xiaoxiao Ge, Jie Sun, Bangyong Zhang, Yuhan Zhang, Jinyuan Xiao, Li Zhang, Hongyun Zhao

Journal for ImmunoTherapy of Cancer Jun 2023, 11 (6) e006654; DOI: 10.1136/jitc-2022-006654

Main menu

Immunohistochemistry

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunohistochemistry

Pages